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Introduction: Anaplastic thyroid carcinoma (ATC) is characterized by local invasiveness, risk of recur-
rence and very poor prognosis. Methods: We retrospectively analysed the multimodality treatment of
ATC in 79 patients considering the impact of surgery on survival. Results: Patients were divided in two
age groups A and B (cut-off 75 years) and in two size subgroups (cut-off 5 cm). Surgery was performed in
78.5% patients of group A and 32.4% of B (p < 0.05). Radiation respectively in 73.8% and 43.2% (p < 0.05).
Tracheostomy and endoprosthesis were used in 45.2% and 16.6% in group A and in 43.2% and 35.1% in
group B. The use of tracheostomy was signiﬁcantly higher (p < 0.05) in larger tumours. In group B
comparing operated and not operated patients signiﬁcant difference in survival was observed for larger
tumours (p ¼ 0.043). In Kaplan Meir analysis signiﬁcant difference in survival was observed comparing
surgical and no surgical patients of all four subgroups. Surgery plus radiotherapy offered a signiﬁcant
better outcome in smaller tumours (p ¼ 0.017). Considering the effect of the single treatment, compared
to no treatment at all, survival is signiﬁcantly improved by surgery for smaller and larger tumours
respectively with 4.42 (p ¼ 0.001) and with 3.5 months (p ¼ 0.0001) and by radiotherapy respectively
with 3.44 and with 3.28 months (p ¼ 0.047 and p ¼ 0.0001). Conclusion: In elderly patients with ATC,
although poor prognosis, surgery is still fundamental in the multimodality treatment with signiﬁcant
advantage in selected patients. Nevertheless most of elderly patients with large tumours are suitable
only for palliative management.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Anaplastic thyroid carcinoma (ATC) is a rare condition repre-
senting only 1.5% of all thyroid cancers. General incidence of thyroid
cancer is increasing worldwide and speciﬁcally in Umbria region,
Italy, where, compared to the national data, it counts in the local
cancer register as the height cancer for incidence [1]. The 5-years
survival rate is 94% for differentiated tumours (DTC) but in case
of ATC it decreases to 5.6e11.4%, with a median life expectancy ofe Specialita Chirurgiche, S.
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by Elsevier Ltd. All rights reservedabout 4e9 months and only 10%e15% of patients alive at two years
in sharp contrast to what observed in DTC [2,3]. The peak of inci-
dence is in the sixth and seventh decades, with signiﬁcant obser-
vation also in very elderly patients over 75-years-old [1]. Females
are mostly affected with a ratio of 5 to 1 compared to males [1].
A large portion of ATCs are diagnosed in patients with history of
longstanding goitre or incompletely treated papillary or follicular
thyroid carcinomas, supposing a derivation from a terminal dedif-
ferentiation of differentiated carcinoma. In fact papillary structure
or follicular components are revealed in focal areas of the tumour
among the classical histopathologic patterns of ATC (squamoid,
spindle cell and giant cell) [4]. As in follicular thyroid carcinomas
RAS molecular mutations are seldom observed in ATC [5].
At the time of ﬁrst clinical observation patients with ATC usually
present a rapidly enlarging anterior neck mass, with compressive
symptoms such as dyspnoea, dysphagia and vocal cord paralysis.
Surrounding structures are invaded in almost 70% of the patients as.
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(44%), laryngeal nerve (27%) and larynx (13%). Lymph node me-
tastases are observed in almost 40% of the patients. Distant me-
tastases are observed in up to 50% of cases at the time of diagnosis.
The most frequent site of distant metastasis is the lung, followed by
bone, skin and brain [4,6]. Death is often caused by tracheal and
oesophageal invasion and obstruction, as well as by consequences
of metastatic disease.
Multimodality treatment advocated by many authors vs no
treatment at all, is proposed to control symptoms with palliative
intent and as an attempt to increase survival [4,6]. Distinguishing
treatment effects from clinical course itself is difﬁcult and it rep-
resents the main criticism in the acceptance of multimodality
approach as a gold standard of treatment [7].
Aim of the present study is the analysis of the impact of surgical
in ATC treatment compared to palliative procedures in elderly pa-
tients over 75 years-old.
2. Patients and methods
2.1. Patients
We retrospectively reviewed 79 consecutive patients with ATC
referred to the Unit of Endocrine Surgery, S. Maria University
Hospital, Terni, University of Perugia between 1996 and 2013.
Accurate staging was carried out with laryngoscopy, neck ul-
trasonography, bone scan and computed tomography (CT) of head,
neck, mediastinum, thorax, and abdomen to determine the extent
of inﬁltration by the tumour. Follow-up was performed after
discharge in the outpatient department, by the same diagnostic
investigations and the overall survival was considered in months.
Multidisciplinary evaluation of patients affected by ATC was
carried out in each case. Patients were allocated to surgery, radio-
therapy, chemotherapy, or a combination of treatment or even just
to palliative procedures according to the pre-operative evaluation
and staging and later on considering ﬁnal histology and clinical
course. No demographic data were considered relevant to allocate
of principle patients to the different treatment groups. The protocol
was mainly dependent on clinical criteria and on the necessity of
symptoms control and tumour treatment.
2.2. Surgery
All the surgical procedures were carried out in the endocrine
surgery unit (AFOI, Area Funzionale Omogenea Interaziendale) of
Umbria region, by the same surgical team, with standard surgicalTable 1
Groups division related to the different treatment and general survival.
Group Subgroup n Surgery 
(n/total) 
No 
surgery 
(n/total) 
Tracheostomy
(n/total) 
En
< 5cm 30 25/30 
(83.3%) 
5/30 
(16.7%) 
11/30 
(36.6%) 
A 
 (< 75 
years) >5 cm 12 8/12 
(66.6%) 
4/12 
(23.4%) 
8/12 
(66.6%) 
< 5cm 14 7/14 
(50%) 
7/14 
(50%) 
3/14 
(21.4%) 
B  
(> 75 
years) >5 cm 23 5/23 
(21.7%) 
18/23 
(78.3) 
13/23 
(56.5%) technique according to the protocol in use for the treatment of ATC.
The surgical procedure was identiﬁed as total thyroidectomy, lo-
bectomy or debulking. Total thyroidectomy denotes the removal of
both lobes and the isthmus. Lobectomy considers resection of one
entire lobe and of the isthmus. Debulking is deﬁned as a tumours
reduction of more than 90%. Total thyroidectomy was indicated in
loco-regional resectable disease. In case of invasive extended tu-
mours thyroidectomy less than total or just debulking procedures
were chosen in order to provide a biopsy and symptoms relief. The
dissection was operated aiming preliminary superior and inferior
laryngeal nerves identiﬁcation, the inferior was followed till the
larynx when technically feasible. In all patients a Jackson Pratt
drainage was used and removed according to the clinical course.2.3. Management of airways obstruction
Tracheostomy and endoprosthesis were used in combination
with surgery or alone as primary treatment in the management of
airways obstruction by large ATC compressing or inﬁltrating the
trachea. The indication for both treatments was given considering
emergency situation with severe dyspnoea, speciﬁc intraoperative
ﬁndings with the necessity of airways control or cases in which
patients were not suitable for surgical resection but only for
symptoms relief or even as airways protection after radical surgery.2.4. Radiotherapy
The treatment included adoption of radiotherapy and chemo-
therapy usually in a postoperative adjuvant combined modality or
primarily with palliative intent. Postoperative radiotherapy ad-
ministers high doses, using a hyperfractionated accelerated
regimen delivered by linear accelerators (4e25 MV photon or
9e17 MeV electron). The radiation dose prescribed was greater
than 40 Gy in radical radiotherapy. Themedian andmost frequently
prescribed dose was 60 Gy. Radiation total dose was 40 Gy or less in
the palliative radiotherapy group.2.5. Chemotherapy
Chemotherapy included the combination of doxorubicin
(50e60 mg/m2/d) and cisplatin (100 mg/m2/d) as standard treat-
ment. More recently paclitaxel plus carboplatin and sorafenib were
used in selective not responsive cases.doprosthesis
(n/total) 
Radiotherapy 
(n/total) 
Mean 
survival 
(months) 
p-value 
(N.S.>0.05 
            *<0.05) 
7/30 
(23.3%) 
22/30 
(73.3%) 
6.7 
0/12 
(0%) 
9/12 
(75%) 
4.6     N.S. 
6/14 
(42.8%) 
8/14 
(57.1%) 
4.4 
7/23 
(30.43%) 
8/23 
(34.7%) 
3       N.S.
          * 
     N.S. 
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Weused Student's t test for analysis of variance between groups.
Survival curves were generated using the KaplaneMeier method,
and the log-rank test was used for univariate analysis. For multi-
variate survival analysis, a Cox proportional hazards model was
used. A p-value <0.05 was considered statistically signiﬁcant. All of
the data were analysed using XLSTAT (Addinsoft, New York, NY,
USA).
3. Results
The cases included 79 patients, 44 females (55.7%) and 35males
(44.3%), with a mean age of 72.6 (±8.7) years. For statistical com-
parison patients were divided in two groups: group A including
patients younger than 75 years-old (n ¼ 42) and group B patients
older than 75 years-old (n ¼ 37). In each group patients were
divided into two subgroups: tumours less than 5 cm in main size
and those larger than 5 cm respectively 30 and 12 patients in group
A and 14 and 23 in group B.
The rate of the different treatment adopted in each group are
summarized in Table 1. We evaluated use of surgery, radiotherapy,
tracheostomy/endoprosthesis and survival in the different groups.
Thirty-three patients (78.5%) underwent surgery in group A
respectively 25 out of 30 (83.3%) with tumours less than 5 cm and 8
out of 12 (66.6%) with tumours larger than 5 cm.
Twelve patients (32.4%) underwent surgery in group B with 7
out of 14 (50%) and 5 out of 23 (21.7%) respectively for the sub-
groups of tumour size. The difference between group A vs B and the
relative subgroups were signiﬁcant (p < 0.05). The surgical pro-
cedures adopted in the different groups are summarized in Table 2.
A signiﬁcant difference (p < 0.05) was observed in the indication
and feasibility of total thyroidectomy in younger patients with
smaller tumours compared to the other groups. Debulking resec-
tion was limited to rare cases (n ¼ 3) and even lobectomy was
limited to few case (n¼ 5) and never applicable in old patients with
large tumours. All patients not undergone surgery, 9 of group A plus
25 of group B, presented contraindications to operation including:
advanced stage with metastases (respectively n ¼ 2 and n ¼ 12),
severe clinical conditions with poor prognosis for which patients
were not suitable for surgery (respectively n¼ 2 and n¼ 7) and not
resectable tumours for too extensive local invasiveness (respec-
tively n ¼ 3 and n ¼ 8).
The rate of radiated patients of 73.8% in group A was signiﬁ-
cantly higher (p < 0.05) than the rate of 43.2% observed in group B,
having only 34.7% of older patients with tumours larger than 5 cm
referred to radiotherapy. In terms of palliative treatment trache-
ostomy and endoprosthesis were used respectively in 45.2% and
16.6% in group A and in 43.2% and 35.1% in group B. In both group A
and B the use of tracheostomy was signiﬁcantly higher (p < 0.05) in
tumours larger than 5 cm. Adequate control of symptoms was ob-
tained in almost all symptomatic patients treated both with cura-
tive and palliative intent.
Themean survival in all 79 patients was 5.35 (±3.2) months. The
mean survival rate observed was 6.7 (±2.09) and 4.6 (±1.89)
months in patients of group A respectively for tumours smaller andTable 2
Type of surgical resection in the different groups.
Group Total thyroidectomy Lobectomy Debulking
A < 5 cm 23 2 /
A > 5 cm 4 2 2
B < 5 cm 6 1 /
B > 5 cm 4 / 1larger than 5 cm and respectively, 4.4 (±2.5) and 3 (±2.67) months
in patients of group B. Considering operated and not operated pa-
tients in each subgroup the only signiﬁcant difference was
observed comparing the subgroups of smaller tumours of group A
and larger of B (respectively p ¼ 0.048 and p ¼ 0.043) (Fig. 1). In
Kaplan Meir analysis, signiﬁcant difference in survival was
observed comparing surgical and no surgical patients of all four
subgroups, having in tumours smaller and larger than 5 cm,
respectively p < 0.001 and p < 0.005 (Fig. 2B) and D)). When
observing older patients of group B alone, a signiﬁcant difference
was evident comparing operated vs not operated patients in tu-
mours larger than 5 cm (p < 0.05) but not those in with tumours
less than 5 cm (Fig. 2A) and C)). Multidisciplinary treatment
combining surgery to radiotherapy offered a signiﬁcant better
outcome in tumours smaller than 5 cm compared to larger ones,
respectively 7.73 and 6.20 months (p ¼ 0.017). Considering the ef-
fect of the single treatment, survival is signiﬁcantly improved by
surgery for smaller tumours with 4.42 (p ¼ 0.001) and for larger
ones with 3.5 months (p ¼ 0.0001) and by radiotherapy respec-
tively with 3.44 and with 3.28 months (p ¼ 0.047 and p ¼ 0.0001),
compared to no treatment at all which shows survival of 2.90 and
1.86 months, respectively for smaller and larger tumours.
4. Discussion
In patients with ATC, the effects of surgery, radiotherapy and
chemotherapy on local control or on improvement of survival are
unclear. Although some studies have shown no survival beneﬁt
from resection, radiation therapy, or chemotherapy, other authors
suggested that multimodality therapy may be beneﬁcial in some
patients with ATC [4e10]. A major confounding factor in deter-
mining the effect of treatment on outcome might be related to the
evidence that patients who usually undergo surgical resection and
radiation treatment often present less extensive disease at ﬁrst
observation.
ATC typically has its peak of incidence in the sixth and seventh
decades and it is associated to very poor prognosis presenting
usually local invasive disease and distant metastases at the time of
diagnosis. The rate of very old patients with ATC is progressively
increasing [1] and this suggests a speciﬁc investigation on which is
the impact of the treatment on these fragile patients with higher
comorbidity and especially if it is useful to treat or better just to
palliate them, if no beneﬁt in survival is observed.
It is generally accepted that in patients with ATC, usually
treatment is palliative rather than therapeutic and is based on a
multimodality approach which is the only chance to improve sur-
vival and quality of life [4].
Multidisciplinary evaluation of patients affected by ATC is
necessary in each case. Patients undergo surgery, radiotherapy,
chemotherapy, or a combination of treatment considering onco-
logic stage at ﬁrst diagnosis, symptoms at clinical presentation and
clinical course. Excluding emergency procedures to treat life
threatening conditions such acute dyspnoea for tracheal
compression, all the other patients are treatedwith palliative intent
in order to control symptoms or with curative intent in limited
invasive tumours. In our setting all cases received a multidisci-
plinary evaluation with standard application of the different
treatment protocols.
Surgery is usually the ﬁrst approach used to reduce the tumour
burden and improve at least compressive complications on airways
although, up to one-third of patients at the time of clinical pre-
sentation results unsuitable for radical surgery and they usually
undergo subtotal resection with palliative intent [4e7].
We observed a very low rate of radiated elderly patients in
group B and this is associated to reduced palliative effects, usually
Fig. 1. Survival related to group treatment. * denotes p < 0.05, N.S. denotes no signiﬁcant difference.
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procedures as the only possible treatments in very aggressive tu-
mours. Palliative procedures in association to surgery or as primary
treatment included tracheostomy and endoprosthesis insertion.
Tracheostomy was carried out in half of patients as primary treat-
ment not associated to surgery and was prevalent in smaller tu-
mours. Use of endoprosthesis was limited to 25% of patients and
was not associated to surgery in the 70% of cases and mostly
indicated in patients with large tumours. Both palliative options of
tracheostomy and endoprosthesis were signiﬁcantly more used in
patients of all ages, when the tumour was larger than 5 cm. This
conﬁrms a speciﬁc role of the palliative treatment as ﬁrst option for
most of the elderly patients with large tumours. In fact those pa-
tients not suitable for surgery alone or in association to radio-
therapy, except for few terminal cases, are anyway approachedwith
tracheostomy and endoprosthesis and referred tomedical palliative
care. Surgery represents an important option when radiotherapy is
not applicable, but in our series even surgery in elderly patients is
less adopted compared to younger ones. In fact the rate of surgical
respectability decreases with increasing age and size.
For limited disease, in with no local neither general contrain-
dications, total thyroidectomy appears as the best option. Even in
the elderly patients it is the only treatment in association to
radiotherapy, when feasible, or to palliative procedures and even
alone, to produce a signiﬁcant increase in survival, although limited
to very few case, compared to the mean mortality observed in this
group.
Kebebew and al [7] found that only patient age at diagnosis and
the presence of intrathyroidal ATC were independent predictors of
lower cause-speciﬁc mortality. In the above study was found a
28.3% difference in the cause-speciﬁc mortality between patients
older than 60 years and patients younger than 60 years and there
was a 44.9% difference in the cause-speciﬁc mortality at 1-year
follow-up between patients who had distant metastasis and pa-
tients who had intrathyroidal ATC [7]. Differently consistent clinical
experience from the Mayo Clinic deﬁned histologic type of cell, sizeof lesion (6 cm or larger), surgical treatment, local invasiveness and
metastatic disease as potential predictors of poor survival [11].
We either experienced a signiﬁcant relation between size of
tumour and advanced age with poor survival and it is probably due
to the limited indication to radical total thyroidectomy in case of
larger tumours or to limited eligibility to surgery and radiotherapy
for severe comorbidity in elderly patients, with prudential limita-
tion of aggressive approaches, in consideration of the poor prog-
nosis expected. In our series surgery as primary treatment was
possible in 55% of all patients, in the younger ones respectively in
83% and 66.6% of small and larger tumours, whereas the corre-
spondent rates for elderly patients were of 50% and 21%.
Surgical treatment is primarily indicated for relief of airway
obstruction. Local control of disease is an important component of
clinical management but in some experience total thyroidectomy
and radical neck dissection may have no advantage over a less
aggressive surgical approach [12,13].
In our experience total thyroidectomy can be recommended if
cervical and mediastinal disease can be resected in cases of limited
disease. Differently in case of invasive extended tumours at the
time of diagnosis, debulking can be considered an adequate option
providing as well a biopsy for pathological diagnosis and partially
symptoms relief as previously shown by other authors [4].
We experienced that surgery as ﬁrst step followed by chemo-
radiotherapy can signiﬁcantly improve survival in patients with
initial stage of ATC. Kebebew et al. in a subgroup analysis, reported
that combined surgical resection and external beam radiation
decreased the cause-speciﬁc mortality rate signiﬁcantly in patients
with regional and distant disease, but not in patients with only
intrathyroidal ATC whose those younger than 60 years old
appeared to have a better prognosis than older patients with
distant metastases [7].
Usually patients with advanced disease present very poor
prognosis, with an overall survival of about 3e6 months [7]. In our
series patients with not metastatic but locally invasive disease, not
suitable for primary surgical resection were referred to chemo-
Fig. 2. Results of survival distribution with Kaplan Meier analysis comparing groups patients underwent or not to surgery. A) with Log-rank p < 0.05, signiﬁcant, B) with Log-rank
p < 0.05, signiﬁcant, C) with Log-rank p > 0.05, not signiﬁcant (NS), D) with Log-rank p < 0.05, signiﬁcant.
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showed in a previous publication from our group [14]. Radio-
therapy in the past was used exclusively in postoperative setting to
stabilize surgical excisionwhereas nowadays it can be either part of
neoadjuvant treatment with higher hyperfractionated doses and
can be indicated to control tumour local invasion, in delaying local
recurrence and preventing thoracic outlet obstruction and meta-
static progression [15].
Since ATC is a rapidly dividing tumour, hyper-fractionated
radiotherapy minimizes the opportunity for tumour cells to
recover between treatments.
Patients not suitable for surgery at the time of diagnosis usually
may be referred to a combination of chemo/radiotherapy although
toxicity seriously affect the clinical course [16e19]. In our series
radiotherapy was adopted in association to surgery in two thirds of
patients and it was mainly used in smaller tumour (almost 70%).
We observed that radiotherapy alone offers a signiﬁcant improve insurvival compared to no treatment, especially for larger tumours
but as above, its use received limited indication in elderly patients
with larger tumours, limiting the treatment options just to airways
obstruction palliation if surgery was as well contraindicated.
We experienced that surgery when applicable, was the essential
element of patient management. Similarly other authors reported
that nearly all long-term survivors with ATC have had surgery as
part of their treatment [13]. Our results conﬁrm that multidisci-
plinary treatment combining surgery to radiotherapy offers a sig-
niﬁcant better outcome especially in tumours smaller than 5 cm
compared to larger ones. Nevertheless when dealing with elderly
patients surgery alone or in association with tracheostomy/endo-
prosthesis and radiotherapy, in selected patients, also for larger
tumours, gains a signiﬁcant improvement in survival although the
prognosis remains very poor.
The role of radical surgery was supported by Haigh et al. [20]
examining a restricted group of long-term survivors treated with
A. Polistena et al. / International Journal of Surgery 12 (2014) S170eS176 S175surgery followed by RT/chemotherapy. More speciﬁcally, those
patients who underwent a potentially curative resection had a
median survival of 43 months compared to 3months for those with
a palliative resection. Swaak-Kragten et al. [15] observed that pa-
tients with R0/R1 resection undergone protocol of chemoradiation
achieved a local complete response rate of 89%, compared to only
3% for not radiated patients without R0/R1 resection. Complete
local response resulted in longer median survival (7 months vs 3
months) and improved 1-year overall survival (32% vs 9%). Lev-
endag et al. [21] also supported the fundamental role of a curative
resection for the success of treatment. The above experiences
conﬁrm our observation about the central role of surgery in the
treatment of ATC, with increased chance for long-term survival in
selected patients.
This approach, if a low incidence of perioperative complications
is possible, might be justiﬁed for all ATC patients and even for
elderly ones [19,22e24].
In our study a major confounding factor in determining the ef-
fect of treatment on outcome has been selection bias, because pa-
tients who undergo surgical resection alone or in association to
radiation often have less extensive disease and minor comorbidity.
Although it is impossible to control for such factors in a retro-
spective study, it appears clear than when applicable a multidisci-
plinary approach is mandatory in the treatment of ATC, considering
the combination of surgery and radiotherapy the fundamental
options to achieve symptoms control and attempt to improve sur-
vival. When examining a cohort of elderly patients, especially with
large tumours and in presence of severe comorbidity, we must
consider that, although signiﬁcant difference in survival are
potentially offered to patients by a surgical approach, in most of
them a limited palliation with tracheostomy or endoprosthesis
might be reasonable and it is actually the more used approach.
Nevertheless is common opinion that further, multicentric studies
are needed to conﬁrm the real impact of surgery alone or as part of
a multimodality treatment in ATC and to standardize the approach
to elderly patients.5. Conclusion
In summary, ATC is characterized by aggressive behaviour with a
very poor prognosis especially in case of large tumours and elderly
patients. Results coming from single modality therapies are usually
unsatisfactory, therefore multimodality therapy has progressively
become the treatment of choice. Although the prognosis remains
very poor, in elderly selected patients, a combination of surgery
plus radiotherapy offers a signiﬁcant increased survival, being total
radical thyroidectomy an essential element of the multimodality
treatment. Nevertheless in the elderly in presence of large ATC,
since limited eligibility to surgery and radiotherapy, tracheostomy
and endoprosthesis, with palliative intent on airways, are the
mostly adopted options.Ethical approval
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